These results are consistent with the many previous works showing that fibronectin contributes to tumor progression in breast, lung, and thyroid cancer through the activation of multiple oncogenic pathways, such as Akt, extracellular signal-regulated kinase, and signal transducer and activator of transcription 3 [39-41]. Here, STAT3 is linked to thyroid gland carcinoma.